On the morning of November 29, a screenshot circulated online, which read that Rao Yi’s real name reported academic fraud by three scientists in China. Rao Yi became President of Capital Medical University in June this year and is also a tenured professor at the School of Life Sciences, Peking University. China Newsweek sent the screenshots to Rao Yi himself for proof. Rao Yi replied: “No send, there have been drafts.” “
The first thing mentioned in this circulating report letter is that Li Hongliang was suspected of fraud: “Your committee should effectively and boldly thoroughly investigate Li Hongliang’s 17 years of blatant fraud at Wuhan University Medical University.” “
In January 2018, the new scientific media “intellectuals” took the lead in breaking the news of the alleged fraud of Li Hongliang’s paper, a professor at Wuhan University. In 2017, Li Hongliang published four articles in Nature Medicine, which had a factor of 30, and Ho Wenzhe, a special expert at Wuhan University’s “Thousand People Project”, reported to Intellectuals that two of the papers were suspected of fraud. Rao Yi is one of the three founders of “Intellectuals” and serves as its editor-in-chief.
On January 29, 2018, Wuhan University’s official microblog posted “Investigation Opinions on The Reported Academic Misconduct of Li Hongliang’s Team”, which concluded that there were no academic frauds in the content of the report ingress of Li Hongliang’s team, but there were individual omissions in the process of writing the paper.
According to the official website of Wuhan University, Li Hongliang is currently the dean of Wuda Foundation Medical College, director of the Animal Experimental Center, deputy director of the Institute of Cardiovascular Disease of Wuhan University, director of the Medical Science Research Center of Zhongnan Hospital, winner of the National Distinguished Youth Fund, a leader in science and technology innovation in the Ministry of Science and Technology, and a leader in the National “People’s Program”.
The second party mentioned in the above-mentioned report letter is Yan Gang, a member of the Chinese Academy of Sciences. The original text reads: “Your committee should seriously investigate the Chinese Academy of Sciences Shanghai Institute of Life Sciences Biochemical Cell Research Institute (editor’s note: should be “member”) Yan gang, in 1999, with your three funds (39630130, 39625015 and 39825110) to support its published papers (Ling et al. PANS96:7922-7927). “
After the reporter inquiry, the three strings mentioned in this paragraph are the approval number of the three projects funded by the National Natural Science Foundation of China, of which the first two projects can be found in charge of the steel. Judging from this, this is a letter of report to be sent to the NSFC.
The paper mentioned in this paragraph was published in the Proceedings of the National Academy of Sciences (PNAS) in 1999 under the title “Five-span membrane domain is sufficient as a G-protein coupling receptor: functional five-span membrane domain promo factor receptor”, and Yan Gang is the author of the newsletter and Malan is the co-author. Yan Gang has served as the director of the Shanghai Institute of Life Sciences of the Chinese Academy of Sciences, Tongji University President, in 1999 was elected a member of the Chinese Academy of Sciences, is now the President of the Chinese Society of Cell Biology. In 2019, Yan Gang’s wife, Ma Lan, a professor of medical school at Fudan University, was also elected a member of the Chinese Academy of Sciences.
The third paper, reported by Rao Yi, was published in Cell Research in September, and he is the editor-in-chief of the magazine. The paper is entitled “The treatment of oligosaccharides reshaping the gut microbiome, inhibiting the inflammation of the amino acid-type nerve of gut bacteria, and inhibiting the progression of Alzheimer’s disease.” On November 2nd, GV-971, a new drug used by the State Drug Administration for the treatment of Alzheimer’s disease, was “conditionally approved” by the State Drug Administration, and the commodity name “Nine Phase 1” is based on the mechanism of action explained in this article. Geng Meiyu, the main inventor of the drug and the academic director of the Shanghai Institute of Pharmaceutical Research of the Chinese Academy of Sciences, is the author of this paper.
In this paper, Geng Meiyu’s team proposed the mechanism of GV-971: by reshaping the balance of the intestinal flora, reducing the accumulation of peripheral-related metabolites phenylalanine/isolelinine, reducing the inflammation of nerves in the brain, thereby improving cognitive impairment, and achieving the effect of treating AD. “This article is impossible without fraud. The report said.
China Newsweek asked Rao about why the draft of the report letter would be leaked and what to do next, but received no further comment. Below the “Rao Yi” in this report letter, the parenthesis is stated as follows: on behalf of the individual, not on behalf of any unit.
29, “Beijing Youth Daily” reporter from the National Natural Science Foundation of China was informed that the commission is currently investigating and verifying the matter.
As of the time of writing, there has been no response from The Steel. China Newsweek will continue to monitor the progress of this matter.